In the summer of 2022 something began to go wrong at an outpatient surgical center in North Dallas. Patients were being sent from it to hospitals in emergencies that no one there could explain, and the center's own reviews found nothing that tied their cases together. On June 21, 2022, Melanie Kaspar died. Her death would hang over the case for the next four years without ever becoming a count on which he was tried.
The man later convicted in the case worked at the center. Raynaldo Rivera Ortiz Jr., an anesthesiologist who had practiced in the Dallas area for years through companies of his own, was arrested by federal agents in September 2022. In April 2024 a federal jury in Dallas convicted him of five counts of Tampering with Consumer Products, four of them resulting in serious bodily injury, and five counts of Adulteration of Drug. He was never tried for her death, and no jury ever decided whether he caused it. At sentencing in November 2024 the judge found that he had, and imposed the statutory maximum on every count, each to run consecutively: 2,280 months, or 190 years. The Fifth Circuit affirmed on May 20, 2026, and the Supreme Court denied certiorari on November 9, 2026.
Ortiz had begun taking cases at the center in May 2022. Over the weeks that followed, patients of different ages and histories, under different surgeons, ran into trouble that had no obvious cause. At the time, no one at the center suspected him.
In August the pattern quickened. The four patients whose cases became the injury counts of the indictment were harmed on August 4, 9, 19 and 24, 2022. After the last of them, a doctor at the center voiced his suspicions, and that same day the matter was reported to the Food and Drug Administration.
Agents of the FDA's Office of Criminal Investigations, working with the Dallas Police Department and other agencies, took up the inquiry and within weeks had narrowed it to one man. They arrested Ortiz on September 14, 2022, three weeks after the FDA was first alerted. He denied doing anything wrong. The criminal complaint on which he was arrested charged him with tampering with a consumer product causing death and with intentional drug adulteration.
On October 5, 2022, a federal grand jury in Dallas returned a ten-count indictment. Eight counts rested on the four August cases, two for each patient. The last two concerned a product recovered unused from the center's stock. The June death, which lay behind the complaint's charge of causing death, was described in the indictment but was not made a count. Ortiz pleaded not guilty to every charge.
The trial opened in federal court in Dallas on April 1, 2024, and the government's case was circumstantial from beginning to end. The four patients named in the injury counts testified, along with doctors and staff from the center and federal investigators. The defense argued that each emergency had its own explanation and that the case against him rested on coincidence. Over its objection, the jury heard evidence about the death, which was not a count of the indictment, with an instruction that it could weigh that evidence only on intent, motive and opportunity, never as proof that he had committed the acts charged. Ortiz did not testify.
On April 12, 2024, the jury found him guilty on all ten counts. On November 20, 2024, the court sentenced him to 240 months on each of nine counts and 120 months on the tenth, all consecutive, for a total of 2,280 months.
On appeal he argued that the evidence was insufficient, that the evidence of the death should never have reached the jury, and two further points about a government expert and the prosecution's closing argument. On May 20, 2026, a panel of the Fifth Circuit affirmed in an unpublished opinion. It held that there was sufficient evidence for the jury to convict on all counts. On the evidence of the death it assumed, without deciding, that admitting it under the federal rules of evidence had been error, and held that the government had met its burden of showing beyond a reasonable doubt that the error was harmless; the jury charge, it added, had mitigated any harm. It held that the trial court had not abused its discretion in letting the government's expert testify after the order excluding witnesses was breached, and that he could not show sufficient prejudice in any event. The remark in the prosecution's closing, to which no objection was made at trial, was not plain error, the panel held, and would have been harmless even if it were. One judge dissented in part, on the death evidence alone. He would have ordered a limited remand so that the trial court could apply the rules of evidence in full in the first instance. Rehearing was denied on July 3, 2026. His petition to the Supreme Court put three questions drawn from the trial: whether a court may let a witness testify after the witness has breached an order excluding witnesses, which side must show prejudice or its absence when a defendant shows such a breach, and whether the presumption that juries follow their instructions can establish that the wrongful admission of evidence was harmless. On November 9, 2026, the Supreme Court denied certiorari, and the convictions and the sentence became final.
Ortiz was never tried for the death of June 21, 2022, and no jury decided whether he caused it. The complaint on which he was arrested charged tampering causing death, and the indictment described the death, but the counts of conviction concern four patients and one unused product from the center's stock. On appeal two judges assumed the evidence of the death should not have been admitted and held the error harmless; the third would have returned the issue to the trial court.
How many patients were harmed beyond the four named in the charges has never been settled by any verdict.
Ortiz denied wrongdoing, pleaded not guilty and did not testify. His defense maintained throughout that each emergency had its own explanation. The jury, the trial court and the appellate majority rejected that view.
2022, May: Ortiz begins working at the surgical center in North Dallas.
2022, June 21: A death later raised in the case, never a count of the indictment.
2022, August 4, 9, 19 and 24: The four patients named in the injury counts are harmed.
2022, August 24: The matter is reported to the FDA.
2022, September 14: Arrested by FDA agents.
2022, October 5: Ten-count federal indictment returned in Dallas.
2024, April 1: Trial opens.
2024, April 12: Convicted on all ten counts.
2024, November 20: Sentenced to 2,280 months (190 years).
2026, May 20: Fifth Circuit affirms, one judge dissenting in part.
2026, July 3: Rehearing denied.
2026, November 9: Supreme Court denies certiorari.